milliplex map kits s100a8 Search Results


99
TaKaRa primescript rt reagent kit takara cat
Primescript Rt Reagent Kit Takara Cat, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primescript rt reagent kit takara cat/product/TaKaRa
Average 99 stars, based on 1 article reviews
primescript rt reagent kit takara cat - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Vector Laboratories hrp streptavidin
Hrp Streptavidin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrp streptavidin/product/Vector Laboratories
Average 99 stars, based on 1 article reviews
hrp streptavidin - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Millipore milliplex map kits s100a8
Milliplex Map Kits S100a8, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/milliplex map kits s100a8/product/Millipore
Average 90 stars, based on 1 article reviews
milliplex map kits s100a8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore milliplex map kits heat shock protein magnetic bead 5-plex kit
Milliplex Map Kits Heat Shock Protein Magnetic Bead 5 Plex Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/milliplex map kits heat shock protein magnetic bead 5-plex kit/product/Millipore
Average 90 stars, based on 1 article reviews
milliplex map kits heat shock protein magnetic bead 5-plex kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore milliplex map kits human cardiovascular disease magnetic bead panel 3—fibrinogen 1 plex
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for <t>Fibrinogen;</t> p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of mitochondrial, cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Milliplex Map Kits Human Cardiovascular Disease Magnetic Bead Panel 3—Fibrinogen 1 Plex, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/milliplex map kits human cardiovascular disease magnetic bead panel 3—fibrinogen 1 plex/product/Millipore
Average 90 stars, based on 1 article reviews
milliplex map kits human cardiovascular disease magnetic bead panel 3—fibrinogen 1 plex - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore milliplex map kits complexes i–iv, human oxidative phosphorylation magnetic bead panel
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Milliplex Map Kits Complexes I–Iv, Human Oxidative Phosphorylation Magnetic Bead Panel, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/milliplex map kits complexes i–iv, human oxidative phosphorylation magnetic bead panel/product/Millipore
Average 90 stars, based on 1 article reviews
milliplex map kits complexes i–iv, human oxidative phosphorylation magnetic bead panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Selleck Chemicals recombinant proteins selumetinib selleckchem
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Recombinant Proteins Selumetinib Selleckchem, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant proteins selumetinib selleckchem/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
recombinant proteins selumetinib selleckchem - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

97
Qiagen rneasy micro kit qiagen
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Rneasy Micro Kit Qiagen, supplied by Qiagen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rneasy micro kit qiagen/product/Qiagen
Average 97 stars, based on 1 article reviews
rneasy micro kit qiagen - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Agilent technologies dna 1000 kit
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Dna 1000 Kit, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna 1000 kit/product/Agilent technologies
Average 90 stars, based on 1 article reviews
dna 1000 kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Selleck Chemicals s1008 trametinib selleckchem
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
S1008 Trametinib Selleckchem, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/s1008 trametinib selleckchem/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
s1008 trametinib selleckchem - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Bristol Myers mouse recombinant peg-ifn lambda 2
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
Mouse Recombinant Peg Ifn Lambda 2, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse recombinant peg-ifn lambda 2/product/Bristol Myers
Average 90 stars, based on 1 article reviews
mouse recombinant peg-ifn lambda 2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Miltenyi Biotec l34966 cd5 ly 1 microbeads
Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of <t>mitochondrial,</t> cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.
L34966 Cd5 Ly 1 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l34966 cd5 ly 1 microbeads/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
l34966 cd5 ly 1 microbeads - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of mitochondrial, cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.

Journal: Frontiers in Immunology

Article Title: Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis

doi: 10.3389/fimmu.2018.01612

Figure Lengend Snippet: Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of mitochondrial, cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.

Article Snippet: Three Milliplex Map kits (EMD Millipore, Bilerica, MA, USA) were used to measure mitochondrial proteins in one assay (Complexes I–IV, Human Oxidative Phosphorylation Magnetic Bead Panel); heat shock proteins in another (Heat Shock Protein Magnetic Bead 5-Plex Kit); Fibrinogen protein in the third (Human Cardiovascular Disease Magnetic Bead Panel 3—Fibrinogen 1 Plex); and S100A8 and S100A12 in the fourth and fifth kit, respectively.

Techniques: Enzyme-linked Immunosorbent Assay, Stable Transfection, Activation Assay, Functional Assay, Negative Control, Positive Control, Inhibition

Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of mitochondrial, cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.

Journal: Frontiers in Immunology

Article Title: Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis

doi: 10.3389/fimmu.2018.01612

Figure Lengend Snippet: Damage-associated molecular patterns (DAMPs) providing inflammatory signal to the receptors toll-like receptor (TLR) 2/4 and 9, are significantly increased in sera of patients with de novo autoimmune hepatitis (DAIH). Sera from liver transplanted patients: with DAIH ( n = 10), without DAIH (LTC) ( n = 19); healthy, non-transplanted children (HC) ( n = 29), and non-transplanted children with autoimmune hepatitis (AIH) ( n = 9), was subjected to (i) qPCR; (ii) ELISA. HEK cells that stably co-express a human TLR2, TLR4, or TLR9 gene and an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene were used to determine activation of TLRs from patient sera. (A,B) significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of cytosolic proteins associated with TLR 2/4 activation in sera of patients with DAIH compared to sera of LTC subjects (qPCR: p < 0.001 for ACTB; p < 0.001 for MT-ATP/complex I; p < 0.001 for Fibrinogen; p < 0.001 for HMGB1, p < 0.001 for HSP70; and p < 0.001 for HSP90, p = 0.05 for HSP60) (ELISA: p = 0.003 for Fibrinogen; p = 0.37 for HMGB1). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of mitochondrial, cytosolic, and functional proteins in sera of patients with DAIH compared to sera of HC subjects (qPCR: p < 0.001 for Fibrinogen, HMGB1, HSP70, HSP90, ACTB, and MT-ATP6, respectively, and p = 0.64 for HSP60). Significant abundance of DAMPs that activate TLRs 2/4 and 9 and levels of functional proteins in sera of patients with AIH compared to sera of HC subjects. [qPCR: p < 0.001 for ACTB (nuclear DNA); p = 0.002 for MT-ATP6 (mitochondrial DNA); p = 0.013 for Fibrinogen; p = 0.008, p = 0.005, and p = 0.008 for HSPs 60, 70 and 90, respectively] (ELISA: p = 0.043 for HMGB1; p = 0.11 for fibrinogen). *** p < 0.001, ** p < 0.01, * p < 0.05. (C,D) Activation of TLRs 2, 4, and 9 reporter cell lines by sera of patients with DAIH. DAIH vs. LTC: ( p = 0.47; TLR2) ( p = 0.008; TLR4) ( p = 0.02; TLR9). DAIH vs. HC: ( p = 0.17; TLR2) ( p < 0.001; TLR4) ( p = 0.001; TLR9). Minus sign: negative control, plus sign: positive control. Representative plate for three patients from each subject group and summary data. (E) Protein inhibition targeting heat shock protein, fibrinogen, and complexes I–III significantly reduced activation of TLR2/4 and TLR9 reporter cell lines, respectively [for TLR 9 reporter cell line inhibition: p = 0.03 for Rotenone (Complex 1), p = 0.03 for Thenoyltrifluoroacetone, TTFA (Complex II), p = 1.0 for Antimycin A (Complex III), p = 0.03 for Complexes I and II, p = 0.03 for Complexes I and III, p = 0.03 for Complexes II and III, p = 0.03 for Complexes I, II, and III; for TLR 4 reporter cell line inhibition: p = 0.06 for fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17- N -Allylamino-17-demethoxygeldanamycin, 17AAG, and p = 0.03 for both HSP90 and fibrinogen inhibitors; for TLR 2 reporter cell line inhibition: p = 0.09 for Fibrinogen inhibitor, p = 0.03 for the HSP90 inhibitor, 17AAG, p = 0.06 for both HSP90 and fibrinogen inhibitors]. (HSP—heat shock protein; positive controls: FSL-1—synthetic diacylated lipoprotein, LPS—lipopolysaccharide, ODN 2006—CpG oligonucleotide). Summary data.

Article Snippet: Three Milliplex Map kits (EMD Millipore, Bilerica, MA, USA) were used to measure mitochondrial proteins in one assay (Complexes I–IV, Human Oxidative Phosphorylation Magnetic Bead Panel); heat shock proteins in another (Heat Shock Protein Magnetic Bead 5-Plex Kit); Fibrinogen protein in the third (Human Cardiovascular Disease Magnetic Bead Panel 3—Fibrinogen 1 Plex); and S100A8 and S100A12 in the fourth and fifth kit, respectively.

Techniques: Enzyme-linked Immunosorbent Assay, Stable Transfection, Activation Assay, Functional Assay, Negative Control, Positive Control, Inhibition